A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro
- Resource Type
- Article
- Source
- In
Surgery January 2021 169(1):34-42 - Subject
- Language
- ISSN
- 0039-6060